Effects of carvedilol on M2 receptors and cholinesterase-positive nerves in adriamycin-induced rat failing heart

Autonomic Neuroscience: Basic and Clinical

Volumn 130, Issue 1-2, 2006, Pages 6-16

  Xu, Xiao Li ^a   Zang, Wei Jin ^a,b   Lu, Jun ^a   Kang, Xin Qin ^a   Li, Ming ^a   Yu, Xiao Jiang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Carvedilol; Cholinesterase positive nerves; Heart failure; Muscarinic receptors

Indexed keywords

BIOTIN; CARVEDILOL; CHOLINESTERASE; DOXORUBICIN; MUSCARINIC M2 RECEPTOR; STREPTAVIDIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAZOLE DERIVATIVE; NERVE PROTEIN; PROPANOLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENCY; ENDOCARDIUM; HEART; HEART FAILURE; HEART LEFT VENTRICLE WALL; HEART NERVE; HISTOCHEMISTRY; IMAGE ANALYSIS; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHOLINERGIC SYSTEM; CONGESTIVE HEART FAILURE; DRUG EFFECT; ENZYMOLOGY; HEART ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONDUCTION SYSTEM; HEART VENTRICLE; INNERVATION; NERVE FIBER; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARBAZOLES; CHOLINESTERASES; DOWN-REGULATION; DOXORUBICIN; ENDOCARDIUM; HEART ATRIA; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; MALE; NERVE FIBERS; NERVE TISSUE PROTEINS; PARASYMPATHETIC NERVOUS SYSTEM; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M2; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33750993459     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2006.04.005     Document Type: Article

References (57)

1. Ali A. Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure. Eur. J. Heart Fail. 5 (2003) 709-715
2. Astra L.I., Hammond R., Tarakji K., and Stephenson L.W. Doxorubicin-induced canine CHF: advantages and disadvantages. J. Card. Surg. 18 (2003) 301-306
3. Brodde O.E., and Kirsten L. Autonomic receptor systems in the failing and aging human heart: similarities and differences. Eur. J. Pharmacol. 500 (2004) 167-176
4. Christine G., Stefan D., and Klaus P. Muscarinic receptors in the failing human heart. Eur. J. Pharmacol. 375 (1999) 197-202
5. Dominique L.G., Alain C.S., Jacques D., Nicolas D., André S., and Pascal M. Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy, An In Vivo PET Study. Circulation 96 (1997) 3416-3422
6. Dorothy E.V., David L.L., Kurt R.S., Peter J.L., Alan M.F., Stephen F.V., and Charles J.H. Impaired cardiac muscarinic receptor function in dogs with heart failure. J. Clin. Invest. 81 (1988) 1836-1842
7. Dulin B., and Abraham W.T. Pharmacology of carvedilol. Am. J. Cardiol. 93 (2004) 3B-6B (Suppl.)
8. 1- and β-adrenoceptor induced inotropic responses in rats with congestive heart failure. Eur. J. Pharmacol. 516 (2005) 51-59
9. Gabriella M., Mario F., Giovanna B., Beatrice R., Luca S., and Giovanni B.P. Long-term treatment with the β-blocker carvedilol restores autonomic tone and responsiveness in patients with moderate heart failure. J. Cardiovasc. Pharmacol. 42 (2003) 125-131
10. Gill D.S., Lintern M.C., Wetherell J., Coote J.H., and Smith M.E. Guinea-pig heart acetylcholinesterase after continuous physostigmine administration. Human Exp. Toxicol. 22 (2003) 373-381
11. Hiroaki K., Ryozo O., and Katsusuke Y. Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels 18 (2003) 32-39
12. Hosenpud J.D., and Greenberg B.H. Congestive Heart Failure. 2nd ed. (2000), Lippincott Williams & Wilkins, Philadelphia 213-232
13. Huang B., Qin D., and Sherif N.E. Spatial alterations of Kv channels expression and K currents in post-MI remodeled rat heart. Cardiovasc. Res. 52 (2001) 246-254
14. Jackson D.A., and Nathanson N.M. Subtype-specific regulation of muscarinic receptor expression and function by heterologous receptor activation. J. Biol. Chem. 270 (1995) 22374-22377
15. Kapadia S., and Dibbs Z. The role of cytokines in failing human hearts. Cardiol. Clin. 16 (1998) 645-646
16. Karnovsky M.J., and Roots L.A. A "direct-coloring" thiocholine method for cholinesterase. J. Histochem. Cytochem. 12 (1964) 219-221
17. Kizaki K., Akatsuka K., Momozaki M., Fujimori Y., Uchide T., Temma K., and Hara Y. Changes in myocardial beta1-adrenergic receptor and stimulatory G-protein gene expression after chronic treatment with doxorubicin in rat. J. Vet. Med. Sci. 66 (2004) 989-992
18. 1B-adrenergic receptors. Cardiovasc. Res. 63 (2004) 662-672
19. 2+ transient. FEBS Lett. 376 (1995) 24-30
20. La Rovere M.T., Mortara A., Pantaleo P., Maestri R., Cobelli F., and Tavazzi L. Scopolamine improves autonomic balance in advanced congestive heart failure. Circulation 90 (1994) 838-843
21. Lefkowitz R.J., Rockman H.A., and Koch W.J. Catecholamines, cardiac beta-adrenergic receptors, and heart failure. Circulation 101 (2000) 1634-1637
22. Lillybeth F., and Robert J.H. Vagal nerve stimulation during muscarinic and beta-adrenergic blockade causes significant coronary artery dilation. J. Auton. Nerv. Syst. 68 (1998) 78-88
23. Lu J., Zang W.J., Yu X.J., Chen L.N., Zhang C.H., and Jia B. Effects of ischaemia-mimetic factors on isolated rat ventricular myocytes. Exp. Physiol. 90 (2005) 497-505
24. Mark E.D., Steve B., Terrone L.R., and Paul E. Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity. Am. J. Physiol.: Heart Circ. Physiol. 285 (2003) H1632-H1640
25. Markus F., Sylvia E., Stephan R., Christoph M., Bodo C., Schlüter K.D., Oliver Z., and Michael B. Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in β-adrenoceptor density and systolic function in rat cardiac myocytes. Cardiovasc. Res. 49 (2001) 371-380
26. Matsui H., Morishima I., Numaguchi Y., Toki Y., Okumura K., and Hayakawa T. Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats. Life Sci. 65 (1999) 1265-1274
27. Meihua L., Can Z., Takayuki S., Toru K., Masaru S., and Kenji S. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109 (2004) 120-124
28. Mertens M., Batink H.D., Mathy M.J., Pfaffendorf M., and Van Z. Reduced muscarinic cholinoceptor density and sensitivity in various models of experimental cardiac hypertrophy. J. Auton. Pharmacol. 15 (1995) 465-474
29. 2 muscarinic receptors in rat ventricles with anti-peptide antibodies. J. Histochem. Cytochem. 42 (1994) 337-343
30. Michiel J.J. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc. Res. 61 (2004) 208-217
31. Mohamed H.E., Asker M.E., Ali S.I., and el-Fattah T.M. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4. J. Pharm. Pharmacol. 56 (2004) 757-768
32. 2-muscarinic receptors in the human right atrium. Br. J. Pharmacol. 101 (1990) 363-369
33. Nagami K., Yoshikawa T., Suzuki M., Wainai Y., Anzai T., and Handa S. Abnormal beta-adrenergic transmembrane signaling in rabbits with adriamycin-induced cardiomyopathy. Jpn. Circ. J. 61 (1997) 249-255
34. Packer M., and Cohn J.N. Consensus recommendations for the management of chronic heart failure: II. Management of heart failure: approaches to the prevention of heart failure. Am. J. Cardiol. 83 (1999) 9A-38A
35. 2 receptors. Life Sci. 60 (1997) 1015-1021
36. Porter T.R., Eckberg D.L., Fritsch J.M., Rea R.F., Beightol L.A., Schmedtje J.F., and Mohanty P.K. Autonomic pathophysiology in heart failure patients: sympathetic-cholinergic interrelations. J. Clin. Invest. 85 (1990) 1362-1371
37. Rabelo E., De Angelis K., Bock P., Gatelli Fernandes T., Cervo F., Bello Klein A., Clausell N., and Claudia Irigoyen M. Baroreflex sensitivity and oxidative stress in adriamycin-induced heart failure. Hypertension 38 (2001) 576-580
38. Rskoski Jr. R., Schmid P.G., Mayer H.E., and Abboud F.M. In vitro acetylcholine biosynthesis in normal and failing guinea pig hearts. Circ. Res. 36 (1975) 547-552
39. Rossig L., Haendeler J., and Mallat Z. Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. J. Am. Coll. Cardiol. 36 (2000) 2081-2089
40. Santos D.L., Moreno A.J.M., Leino R.L., Froberg M.K., and Wallace K.B. Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy. Toxicol. Appl. Pharmacol. 185 (2002) 218-227
41. Schmitz W., Boknik P., Linck B., and Mûller F.U. Adrenergic and muscarinic receptor regulation and therapeutic implications in heart failure. Mol. Cell. Biochem. 157 (1996) 251-258
42. Schwinn D.A., Johnston G.I., and Page S.O. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. J. Pharmacol. Exp. Ther. 272 (1995) 134-142
43. Simon J.C., Robert H.A., Siew Y.H., and Mary N.S. Localization and quantitation of autonomic innervation in the porcine heart: II. Endocardium, myocardium and epicardium. J. Anat. 195 (1999) 359-373
44. Sroka K. On the genesis of myocardial ischemia. Z. Cardiol. 93 (2004) 768-783
45. Stefan D., Chris J.V.K., and Brodde O.E. Muscarinic receptors in the mammalian heart. Pharmacol. Res. 44 (2001) 162-182
46. Steve B., and Mark E.D. Ganglionic mechanisms contribute to diminished vagal control in heart failure. Circulation 99 (1999) 2958-2963
47. Steve B., and Mark E.D. Prevention of diminished parasympathetic control of the heart in experimental heart failure. Am. J. Physiol.: Heart Circ. Physiol. 287 (2004) H1780-H1785
48. Strasser R., Nuchter I., Rauch B., Marquetant R., and Seitz H. Changes in cardiac signal transduction systems in chronic ethanol treatment preceding the development of alcoholic cardiomyopathy. Herz 21 (1996) 232-240
49. Szenczi O., Kemecsei P., Holthuijsen M.F., van Riel N.A., van der Vusse G.J., Pacher P., Szabo C., Kollai M., Ligeti L., and Ivanics T. Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failure. Biochem. Pharmacol. 69 (2005) 725-732
50. Tsuyoshi A., and Toji Y. Adrenergic inhibition of endogenous acetylcholine release on postganglionic cardiac vagal nerve terminals. Cardiovasc. Res. 46 (2000) 531-538
51. Wang H.Z., Han H., Zhang L.M., Shi H., Gernot S., Stanley N., and Wang Z. Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart. Mol. Pharmacol. 59 (2001) 1029-1036
52. 3 muscarinic acetylcholine receptors in mammalian hearts. Br. J. Pharmacol. 142 (2004) 395-408
53. Yamauchi A. Ultrastructure of the innervation of the mammalian heart. In: Challice C.E., and Viragh S. (Eds). Ultrastructure of the Mammalian Heart (1973), Academic Pres., New York
54. Zang W.J., Yu X.J., Honjo H., Kirby M.S., and Boyett M.R. On the role of G protein activation and phosphorylation in desensitization to acetylcholine in guinea-pig atrial cells. J. Physiol. 464 (1993) 649-679
55. Zang W.J., Chen L.N., Yu X.J., Fang P., Lu J., and Sun Q. Comparison of effects of acetylcholine on electromechanical characteristics in guinea-pig atrium and ventricles. Exp. Physiol. 90 (2005) 123-130
56. Zeng J.R., Zang W.J., Lin Y.X., Yu X.J., Chen L.N., Kang X.Q., and Lu J. The comparison of M acetylcholine receptors in atrial and ventricular myocardium of rats, guinea pig and rabbits[J]. Chin. Heart J. 17 (2005) 210-212
57. Zipes D.P. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 82 (1990) 1095-1105